Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Preclinical Reports

Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling

Hu, Tianjun; Shen, Haibo; Huang, Hongbo; Yang, Zhenhua; Zhou, Yinjie; Zhao, Guofang

Author Information
doi: 10.1097/CAD.0000000000000885
  • Buy
  • SDC

Abstract

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.